[go: up one dir, main page]

RU2000124951A - METHOD FOR TREATING TUBERCULOSIS OF RESPIRATORY ORGANS WITH EXPRESSED EXUDATIVE REACTION IN CHILDREN - Google Patents

METHOD FOR TREATING TUBERCULOSIS OF RESPIRATORY ORGANS WITH EXPRESSED EXUDATIVE REACTION IN CHILDREN

Info

Publication number
RU2000124951A
RU2000124951A RU2000124951/14A RU2000124951A RU2000124951A RU 2000124951 A RU2000124951 A RU 2000124951A RU 2000124951/14 A RU2000124951/14 A RU 2000124951/14A RU 2000124951 A RU2000124951 A RU 2000124951A RU 2000124951 A RU2000124951 A RU 2000124951A
Authority
RU
Russia
Prior art keywords
children
expressed
respiratory organs
treating tuberculosis
exudative reaction
Prior art date
Application number
RU2000124951/14A
Other languages
Russian (ru)
Other versions
RU2189234C2 (en
Inventor
Лариса Алексеевна Иванова
Ирина Федоровна Довгалюк
Вероника Владимировна Нергачева
Марина Николаевна Кондакова
Валентина Александровна Целикова
Валентина Васильевна Ватутина
Original Assignee
Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии
Filing date
Publication date
Application filed by Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии filed Critical Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии
Priority to RU2000124951/14A priority Critical patent/RU2189234C2/en
Priority claimed from RU2000124951/14A external-priority patent/RU2189234C2/en
Application granted granted Critical
Publication of RU2189234C2 publication Critical patent/RU2189234C2/en
Publication of RU2000124951A publication Critical patent/RU2000124951A/en

Links

Claims (1)

Способ лечения туберкулеза органов дыхания с выраженной экссудативной реакцией у детей, включающий введение противотуберкулезных препаратов и преднизолона, отличающийся тем, что через 2-3 недели от начала специфической противотуберкулезной химиотерапии применяют азитромицин в течение 5 дней, затем через 1-1,5 месяца назначают преднизолон в дозах 0,2-0,4 мг/кг в течение 3-4 недель с дальнейшим снижением каждые 3-4 дня по 2,5 мг, и, на фоне снижения его доз, назначают повторно азитромицин в течение 5 дней.A method of treating respiratory tuberculosis with a pronounced exudative reaction in children, including the introduction of anti-TB drugs and prednisone, characterized in that after 2-3 weeks from the start of specific anti-TB chemotherapy, azithromycin is used for 5 days, then prednisolone is prescribed after 1-1.5 months in doses of 0.2-0.4 mg / kg for 3-4 weeks, with a further decrease every 3-4 days, 2.5 mg, and, against the background of a decrease in its doses, azithromycin is prescribed again for 5 days.
RU2000124951/14A 2000-10-02 2000-10-02 Method for treating the cases of respiratory organ tuberculosis with marked exudation response in children RU2189234C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000124951/14A RU2189234C2 (en) 2000-10-02 2000-10-02 Method for treating the cases of respiratory organ tuberculosis with marked exudation response in children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000124951/14A RU2189234C2 (en) 2000-10-02 2000-10-02 Method for treating the cases of respiratory organ tuberculosis with marked exudation response in children

Publications (2)

Publication Number Publication Date
RU2189234C2 RU2189234C2 (en) 2002-09-20
RU2000124951A true RU2000124951A (en) 2003-07-10

Family

ID=20240589

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000124951/14A RU2189234C2 (en) 2000-10-02 2000-10-02 Method for treating the cases of respiratory organ tuberculosis with marked exudation response in children

Country Status (1)

Country Link
RU (1) RU2189234C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2234311C1 (en) * 2002-12-15 2004-08-20 Ставропольский научно-исследовательский противочумный институт Method for treatment of brucellosis
RU2239416C2 (en) * 2002-12-15 2004-11-10 Ставропольский научно-исследовательский противочумный институт Method for treatment of brucellosis
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
RU2704816C1 (en) * 2018-12-18 2019-10-31 Федеральное государственное бюджетное научное учреждение "Центральный научно-исследовательский институт туберкулеза" Method for forming a chemotherapy regimen for primary intrathoracic tuberculosis in children from tuberculosis infection centers

Similar Documents

Publication Publication Date Title
ES2172239T3 (en) OSMOTIC SYSTEM OF LIBERATION OF PHARMACOS.
UA41995C2 (en) PHARMACEUTICAL FORM OF AZITROMYCIN WITH CONTROLLED RELEASE (OPTIONS), METHOD OF ITS INTRODUCTION, METHOD OF ITS MANUFACTURE AND METHOD OF TREATMENT
IL150568A0 (en) A controlled release oral drug dosage form
WO2002047667A3 (en) Novel medicament compositions based on anticholinesterase drugs and on a steroid
IS3644A7 (en) Method of preparing a pharmaceutical composition in the form of pellets for the treatment of intestinal inflammation
NO20101070L (en) Method of dosing a drug, as well as dosage form
RU2000124951A (en) METHOD FOR TREATING TUBERCULOSIS OF RESPIRATORY ORGANS WITH EXPRESSED EXUDATIVE REACTION IN CHILDREN
TR199900770T2 (en) Use of an H+, K+-ATPase in the treatment of nasal polyps.
JPS51143128A (en) Exhaust purifying device
EP0271151A3 (en) Azumolene dosage form
RU2000110925A (en) METHOD FOR TREATING LUNG TUBERCULOSIS
JP2002544167A5 (en)
CA2503286A1 (en) Compounds for the treatment of tobacco dependence and withdrawal
JP2005506959A5 (en)
JPS51137016A (en) An exhaust gas purifying apparatus
RU99123225A (en) METHOD FOR TREATING SEVERE BRONCH-OBSTRUCTIVE SYNDROME IN CHILDREN OF EARLY AGE
RU2003102292A (en) METHOD OF ANESTHESIA AT ONCOSURGICAL OPERATIONS ON ABDOMINAL CAVITIES
RU99125561A (en) METHOD FOR TREATING CHRONIC DERMATOSIS
JPS55151511A (en) Antiallergic agent consisting mainly of kynurenic ester derivative
TAKAHASHI et al. STUDIES ON ANTIGENICITY OF SULOCTIDIL
KR950700063A (en) Brofaromine as an agent for treating post-traumatic stress
RU2004132305A (en) METHOD AND MEANS FOR TREATMENT OF Benign Hyperplastic Endometrial Processes
RU2000105967A (en) METHOD FOR TREATING ABSTINENT SYNDROME IN PATIENTS DEPENDING ON TRAMAL
WO2003024394A3 (en) Method of treating benign prostatic hyperplasia and other beingn porstate conditions
WO2003037301A3 (en) Oral dosage forms for improving the bioavailability of therapeutic agents